APYX
Apyx Medical Corporation
NASDAQ · Healthcare · Medical - Devices · US
$3.05
−0.33%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−86.1x
Market Cap
$128.48M
MomentumView details →
1D Return
−0.33%
YTD Return
−12.86%
RSI (14)
36.2
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−86.1x
Market Cap
$128.48M
RSI (14)
36.2
MomentumView details →
1D Return
−0.33%
YTD Return
−12.86%
SummaryUpdated Jun 1, 2026
Apyx Medical Corporation (NASDAQ:APYX) is a Florida-based medical device company that was founded in 1982 and originally operated under the name Bovie Medical Corporation before rebranding in January 2019. The company specializes in developing, manufacturing, and selling advanced energy-based medical devices primarily for the cosmetic surgery and surgical markets worldwide. Apyx went public in January 2019 and has positioned itself as a technology leader in the growing aesthetic medicine sector, particularly focusing on minimally invasive procedures for skin tightening and body contouring.
Similar companies
Latest newsMore news →